Zolpidem ( DrugBank: Zolpidem )

3 diseases

ID	Disease name (Link within this page)	Number of trials
5	Progressive supranuclear palsy	1
6	Parkinson disease	3
46	Malignant rheumatoid arthritis	1

5. Progressive supranuclear palsy

Clinical trials : 89 / Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04014387 (ClinicalTrials.gov)	June 2, 2019	11/4/2019	Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)	Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)	Treatment	Drug: Suvorexant;Drug: Zolpidem;Drug: Placebo oral capsule	University of California, San Francisco	US Department of Veterans Affairs	Recruiting	18 Years	N/A	All	60	Phase 4	United States

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03621046 (ClinicalTrials.gov)	August 20, 2018	6/6/2018	Use of Low-dose Zolpidem in Parkinson's Disease	A Placebo Controlled Double Blind Randomised Controlled Proof of Concept Study of Zolpidemfor the Tr ...	Parkinson Disease	Drug: Zolpidem;Other: Placebo	Aston University	University Hospital Birmingham NHS Foundation Trust	Completed	40 Years	80 Years	All	28	Phase 2	United Kingdom
2	EUCTR2017-004297-34-GB (EUCTR)	31/03/2018	22/06/2018	Use of low-dose zolpidem in Parkinson's.	A placebo controlled double blind randomised controlled proof of concept study of zolpidemfor the tr ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: Stilnoct Product Name: Stilnoct Product Code: 207-3120 INN or Proposed INN: ZolpidemTartrat ...	Aston University	NULL	Not Recruiting			Female: yes Male: yes	28	Phase 2	United Kingdom
3	NCT01351168 (ClinicalTrials.gov)	December 2011	9/5/2011	Use of Zolpidem in Parkinson's Disease	A Randomized, Controlled, Double-Blind, Cross-over Study of Zolpidemfor Patients With Parkinson's Di ...	Parkinson's Disease	Drug: Levodopa;Drug: Zolpidem first dose;Drug: Zolpidem second dose;Drug: sugar pill	Rush University Medical Center	NULL	Withdrawn	30 Years	75 Years	Both	0	Phase 2	United States

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000039116	2020/01/15	15/01/2020	Effects of Sleep Management on Postoperative Pain in patients after total knee arthroplasty. A rando ...	Effects of zolpidemtartrate on Postoperative Pain in patients after total knee arthroplasty. A rando ...	Osteoarthritis, Rheumatoid arthritis	Administration of zolpidemtartrate of 5mg for 7 days after surgery No administration of zolpidemtartr ...	Mito medical center, Mito Kyodo General Hospital, University of Tsukuba	NULL	Pending	20years-old	Not applicable	Male and Female	84	Not selected	Japan